Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Stryker Cited by U.S. FDA for Faulty Hip Parts
Link ID 2420
Title Stryker Cited by U.S. FDA for Faulty Hip Parts
Url http://www.medscape.com/viewarticle/568853?src=rss
Description U.S. regulators have warned medical device maker Stryker Corp about manufacturing problems linked to some malfunctioning hip implant parts. Reuters Health Information
Category Articles > Business of Medicine
Keywords
Date Jan 16, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. The Retainer Model or Single Payer -- What Will Save Primary Care?
  A critical debate on the future of primary care. Where do you stand?
Medscape Family Medicine
Category:   Articles > Business of Medicine


2. Concerns Raised on Delay of Ezetimibe Data
  But lead investigator of the study, Dr John Kastelein, says that rumors suggesting the results are being suppressed because they are negative are completely unfounded. Heartwire
Category:   Articles > Business of Medicine


3. China to Ease Travel Restrictions on HIV-Carriers
  China is to scrap immigration laws that restrict people with HIV/AIDS travelling to the country, a health ministry official and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Thursday. Reuters Health Information
Category:   Articles > Business of Medicine


4. Foodborne Outbreaks From Green Leafy Vegetables Increasing
  Over the past three and a half decades, the United States has seen a substantial increase in the number of foodborne outbreaks linked to consumption of lettuce and other leafy green vegetables, research suggests, and the increase cannot be entirely attributed to Americans eating more salads. Reuters Health Information
Category:   Articles > Business of Medicine


5. Problems With Baxter Heparin Still Unresolved
  Because of continuing severe adverse reactions, Baxter has stopped manufacturing multiple-dose vials of heparin. The FDA is recommending that heparin manufactured by other companies or alternative anticoagulants be used if possible. Medscape Medical News
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS